Intensity Therapeutics Inc (INTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 02-1996 | 02-1995 | 02-1994 | 02-1993 | 02-1992 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 3,960 | 3,910 | 2,472 | 1,216 | 635 |
| TOTAL | $3,960 | $3,910 | $2,472 | $1,216 | $635 |
| Non-Current Assets | |||||
| PPE Net | 5,593 | 2,584 | N/A | 1,800 | 2,092 |
| Investments And Advances | 15,423 | 22,299 | 0 | 0 | 0 |
| Other Non-Current Assets | 6,413 | 5,893 | 3,461 | 3,233 | 3,092 |
| TOTAL | $27,429 | $30,776 | $3,461 | $5,033 | $5,184 |
| Total Assets | $31,389 | $34,686 | $5,933 | $6,249 | $5,819 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,309 | 1,741 | 971 | 891 | 540 |
| Accrued Expenses | 8,515 | 5,207 | 4,012 | 1,995 | 2,145 |
| Other current liabilities | 9,389 | 6,067 | 5,286 | 4,186 | 541 |
| TOTAL | $26,404 | $14,967 | $11,544 | $8,140 | $4,453 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 584 | 200 | 222 | 331 | 284 |
| TOTAL | $584 | $200 | $1,122 | $331 | $284 |
| Total Liabilities | $26,988 | $15,167 | $12,666 | $8,471 | $4,737 |
| Shareholders' Equity | |||||
| Common Shares | 40,283 | 35,529 | 30,096 | 28,691 | 30,627 |
| Other shareholders' equity | 333 | -109 | 227 | 0 | 0 |
| TOTAL | $40,616 | $35,420 | $30,323 | $32,447 | $30,627 |
| Total Liabilities And Equity | $67,604 | $50,587 | $42,989 | $40,918 | $35,364 |